14 min listen
iwMyeloma 2024 Session I: approaching bone disease, clinical trial updates & the value of MRD as an endpoint in trials
FromVJHemOnc Podcast
iwMyeloma 2024 Session I: approaching bone disease, clinical trial updates & the value of MRD as an endpoint in trials
FromVJHemOnc Podcast
ratings:
Length:
27 minutes
Released:
May 10, 2024
Format:
Podcast episode
Description
The 17th International Workshop on Multiple Myeloma (iwMyeloma 2024) was held recently in Miami, FL, and brought together experts from...
The post iwMyeloma 2024 Session I: approaching bone disease, clinical trial updates & the value of MRD as an endpoint in trials appeared first on VJHemOnc.
The post iwMyeloma 2024 Session I: approaching bone disease, clinical trial updates & the value of MRD as an endpoint in trials appeared first on VJHemOnc.
Released:
May 10, 2024
Format:
Podcast episode
Titles in the series (100)
Post-EBMT highlights in acute myeloid leukemia: Acute myeloid leukemia (AML) is the most common type of adult leukemia, with over 19,500 new cases estimated to be... by VJHemOnc Podcast